
Uppsala Reports editor
@UMCGlobalSafety
National differences in identifying products and substances complicate pharmacovigilance. But the IDMP standards promise a harmonised, structured body of definitions. Learn how...
The Identification of Medicinal Products (IDMP) standards promise to harmonise how pharmaceutical products and substances are described around the world. But how will that benefit patients and who will make sure the standards are properly implemented?
Uppsala Monitoring Centre’s Malin Fladvad and Olle Lagerlund join Drug Safety Matters host Federica Santoro to discuss the advantages and challenges of this global standardisation effort.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
To find out even more about how IDMP will affect the future of pharmacovigilance – and what role UMC will play in that future – be sure to visit our information resources at:
To reach more readers, the HSA undertook a digitalisation project of their news bulletin for communicating signal data. The results reveal the impact of going digital.
Technology / 17 May 2023
Now vaccination field workers can collect reports on adverse events following immunisation (AEFI) using a phone, tablet, or laptop even in the remotest of locations.
Technology / 20 September 2022
A new study highlights the gains to be made in time, quality, and consistency from using UMC’s coding engine WHODrug Koda to automate drug coding in post-marketing surveillance.
Technology / 09 May 2022